Cargando…

Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study

Late diagnosis and treatment may increase morbidity and mortality among persons with hepatitis C virus (HCV) infection. We included all participants of the Swiss Hepatitis C Cohort Study (SCCS). We used unadjusted and adjusted logistic and Cox regressions to determine the association between the geo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brezzi, Matteo, Bertisch, Barbara, Roelens, Maroussia, Moradpour, Darius, Terziroli Beretta-Piccoli, Benedetta, Semmo, Nasser, Müllhaupt, Beat, Semela, David, Negro, Francesco, Keiser, Olivia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590815/ https://www.ncbi.nlm.nih.gov/pubmed/31233524 http://dx.doi.org/10.1371/journal.pone.0218706

Ejemplares similares

All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
por: Roelens, Maroussia, et al.
Publicado: (2020)

Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations
por: Bertisch, Barbara, et al.
Publicado: (2016)

A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study
por: Semmo, Nasser, et al.
Publicado: (2020)

Assessing relative COVID-19 mortality: a Swiss population-based study
por: Hothorn, Torsten, et al.
Publicado: (2021)

Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
por: Müllhaupt, Beat, et al.
Publicado: (2018)

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction
por: Bibert, Stéphanie, et al.
Publicado: (2013)

HCV disease burden and population segments in Switzerland
por: Bihl, Florian, et al.
Publicado: (2021)

Mortality trends and causes of death among HIV positive patients at Newlands Clinic in Harare, Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2017)

Autoimmmune hepatitis
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2021)

HLA, gut microbiome and hepatic autoimmunity
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2022)

Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2021)

Clinical Significance of the CCR5delta32 Allele in Hepatitis C
por: Morard, Isabelle, et al.
Publicado: (2014)

Future scenarios for the SARS-CoV-2 epidemic in Switzerland: an age-structured model
por: Estill, Janne, et al.
Publicado: (2021)

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
por: Müllhaupt, Beat, et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C
por: Pfeil, Alena M., et al.
Publicado: (2015)

Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study
por: Yilmaz, Bahtiyar, et al.
Publicado: (2021)

Elbasvir/Grazoprevir, an Alternative in Antiviral Hepatitis C Therapy in Patients under Amiodarone Treatment
por: Weiss, Lina, et al.
Publicado: (2018)

Atovaquone/proguanil‐induced autoimmune‐like hepatitis
por: Terziroli Beretta‐Piccoli, Benedetta, et al.
Publicado: (2017)

A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2019)

Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
por: Ghielmetti, Michele, et al.
Publicado: (2021)

Measuring Timeliness of Outbreak Response in the World Health Organization African Region, 2017–2019
por: Impouma, Benido, et al.
Publicado: (2020)

Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19
por: Fröhlich, Georg Marcus, et al.
Publicado: (2022)

Targeting Endoplasmic Reticulum and/or Mitochondrial Ca(2+) Fluxes as Therapeutic Strategy for HCV Infection
por: Scrima, Rosella, et al.
Publicado: (2018)

Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis
por: Sadeghimehr, Maryam, et al.
Publicado: (2021)

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing
por: About, Frédégonde, et al.
Publicado: (2019)

Neurologic complications of acute hepatitis E virus infection
por: Ripellino, Paolo, et al.
Publicado: (2019)

A Comparison of Initial Antiretroviral Therapy in the Swiss HIV Cohort Study and the Recommendations of the International AIDS Society-USA
por: Wandeler, Gilles, et al.
Publicado: (2011)

Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center
por: Vieira Barbosa, Joana, et al.
Publicado: (2021)

Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development
por: Lange, Christian M., et al.
Publicado: (2013)

Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?
por: Schmidt, Axel J, et al.
Publicado: (2014)

Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review
por: Bronz, Gabriel, et al.
Publicado: (2022)

COVID-19, Coronavirus Vaccines, and Possible Association with Lipschütz Vulvar Ulcer: A Systematic Review
por: Vismara, Stefano A., et al.
Publicado: (2023)

Infections or Vaccines Associated with Finkelstein-Seidlmayer Vasculitis: Systematic Review
por: Bronz, Gabriel, et al.
Publicado: (2022)

Exploring geographic variation of and influencing factors for utilization of four diabetes management measures in Swiss population using claims data
por: Wei, Wenjia, et al.
Publicado: (2020)

Modelling the impact of different testing strategies for HCV infection in Switzerland
por: Sadeghimehr, Maryam, et al.
Publicado: (2019)

Assessing relative COVID-19 mortality during the second wave: a prospective Swiss population-based study
por: Siegfried, Sandra, et al.
Publicado: (2021)

Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study
por: Aebi-Popp, Karoline, et al.
Publicado: (2014)

Zimbabwe’s national third-line antiretroviral therapy program: Cohort description and treatment outcomes
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center
por: Karbeyaz, Fatih, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j7tn53rn5khbr3jibf3336umke